Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian

K. Basen-Engquist*, D. Bodurka-Bevers, M. A. Fitzgerald, K. Webster, D. Cella, S. Hu, D. M. Gershenson

*Corresponding author for this work

Research output: Contribution to journalArticle

170 Citations (Scopus)

Abstract

Purpose: To report the reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) in a consecutive series of outpatients with epithelial ovarian cancer. Patients and Methods: Two hundred thirty-two ovarian cancer patients attending an outpatient gynecologic oncology clinic completed questionnaires at baseline. The patients' FACT-O scores were compared with their performance status, disease stage, treatment status, and other factors hypothesized to be related to quality of life. Patients received a second questionnaire either one week after baseline to assess the instrument's test-retest reliability and/or two months after baseline to evaluate its sensitivity to change in performance status. Results: Internal consistency and test-retest reliability of the FACT-O were adequate. Overall, the scales correlated with other measures as expected; all correlations were in the hypothesized direction. Patients with advanced disease, poor performance status, and who were receiving active treatment had lower scores on physical, functional, and ovarian cancer-specific scales. The total FACT-O and emotional well-being scores were lower for patients with poor performance status and patients in active treatment. The FACT-O total and all subscale scores except emotional well-being were sensitive to decreases in performance status. Conclusion: Overall, the FACT-O provides a reliable and valid assessment of the quality of life of women with ovarian cancer, and is appropriate as a brief quality of life assessment in clinical trials and descriptive studies.

Original languageEnglish (US)
Pages (from-to)1809-1817
Number of pages9
JournalJournal of Clinical Oncology
Volume19
Issue number6
DOIs
StatePublished - Mar 15 2001

Fingerprint

Reproducibility of Results
Ovarian Neoplasms
Therapeutics
Quality of Life
Outpatients
Clinical Trials

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Basen-Engquist, K., Bodurka-Bevers, D., Fitzgerald, M. A., Webster, K., Cella, D., Hu, S., & Gershenson, D. M. (2001). Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian. Journal of Clinical Oncology, 19(6), 1809-1817. https://doi.org/10.1200/JCO.2001.19.6.1809
Basen-Engquist, K. ; Bodurka-Bevers, D. ; Fitzgerald, M. A. ; Webster, K. ; Cella, D. ; Hu, S. ; Gershenson, D. M. / Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian. In: Journal of Clinical Oncology. 2001 ; Vol. 19, No. 6. pp. 1809-1817.
@article{9f632a399c054d6abc2dee8da4f3b788,
title = "Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian",
abstract = "Purpose: To report the reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) in a consecutive series of outpatients with epithelial ovarian cancer. Patients and Methods: Two hundred thirty-two ovarian cancer patients attending an outpatient gynecologic oncology clinic completed questionnaires at baseline. The patients' FACT-O scores were compared with their performance status, disease stage, treatment status, and other factors hypothesized to be related to quality of life. Patients received a second questionnaire either one week after baseline to assess the instrument's test-retest reliability and/or two months after baseline to evaluate its sensitivity to change in performance status. Results: Internal consistency and test-retest reliability of the FACT-O were adequate. Overall, the scales correlated with other measures as expected; all correlations were in the hypothesized direction. Patients with advanced disease, poor performance status, and who were receiving active treatment had lower scores on physical, functional, and ovarian cancer-specific scales. The total FACT-O and emotional well-being scores were lower for patients with poor performance status and patients in active treatment. The FACT-O total and all subscale scores except emotional well-being were sensitive to decreases in performance status. Conclusion: Overall, the FACT-O provides a reliable and valid assessment of the quality of life of women with ovarian cancer, and is appropriate as a brief quality of life assessment in clinical trials and descriptive studies.",
author = "K. Basen-Engquist and D. Bodurka-Bevers and Fitzgerald, {M. A.} and K. Webster and D. Cella and S. Hu and Gershenson, {D. M.}",
year = "2001",
month = "3",
day = "15",
doi = "10.1200/JCO.2001.19.6.1809",
language = "English (US)",
volume = "19",
pages = "1809--1817",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "6",

}

Basen-Engquist, K, Bodurka-Bevers, D, Fitzgerald, MA, Webster, K, Cella, D, Hu, S & Gershenson, DM 2001, 'Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian', Journal of Clinical Oncology, vol. 19, no. 6, pp. 1809-1817. https://doi.org/10.1200/JCO.2001.19.6.1809

Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian. / Basen-Engquist, K.; Bodurka-Bevers, D.; Fitzgerald, M. A.; Webster, K.; Cella, D.; Hu, S.; Gershenson, D. M.

In: Journal of Clinical Oncology, Vol. 19, No. 6, 15.03.2001, p. 1809-1817.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian

AU - Basen-Engquist, K.

AU - Bodurka-Bevers, D.

AU - Fitzgerald, M. A.

AU - Webster, K.

AU - Cella, D.

AU - Hu, S.

AU - Gershenson, D. M.

PY - 2001/3/15

Y1 - 2001/3/15

N2 - Purpose: To report the reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) in a consecutive series of outpatients with epithelial ovarian cancer. Patients and Methods: Two hundred thirty-two ovarian cancer patients attending an outpatient gynecologic oncology clinic completed questionnaires at baseline. The patients' FACT-O scores were compared with their performance status, disease stage, treatment status, and other factors hypothesized to be related to quality of life. Patients received a second questionnaire either one week after baseline to assess the instrument's test-retest reliability and/or two months after baseline to evaluate its sensitivity to change in performance status. Results: Internal consistency and test-retest reliability of the FACT-O were adequate. Overall, the scales correlated with other measures as expected; all correlations were in the hypothesized direction. Patients with advanced disease, poor performance status, and who were receiving active treatment had lower scores on physical, functional, and ovarian cancer-specific scales. The total FACT-O and emotional well-being scores were lower for patients with poor performance status and patients in active treatment. The FACT-O total and all subscale scores except emotional well-being were sensitive to decreases in performance status. Conclusion: Overall, the FACT-O provides a reliable and valid assessment of the quality of life of women with ovarian cancer, and is appropriate as a brief quality of life assessment in clinical trials and descriptive studies.

AB - Purpose: To report the reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) in a consecutive series of outpatients with epithelial ovarian cancer. Patients and Methods: Two hundred thirty-two ovarian cancer patients attending an outpatient gynecologic oncology clinic completed questionnaires at baseline. The patients' FACT-O scores were compared with their performance status, disease stage, treatment status, and other factors hypothesized to be related to quality of life. Patients received a second questionnaire either one week after baseline to assess the instrument's test-retest reliability and/or two months after baseline to evaluate its sensitivity to change in performance status. Results: Internal consistency and test-retest reliability of the FACT-O were adequate. Overall, the scales correlated with other measures as expected; all correlations were in the hypothesized direction. Patients with advanced disease, poor performance status, and who were receiving active treatment had lower scores on physical, functional, and ovarian cancer-specific scales. The total FACT-O and emotional well-being scores were lower for patients with poor performance status and patients in active treatment. The FACT-O total and all subscale scores except emotional well-being were sensitive to decreases in performance status. Conclusion: Overall, the FACT-O provides a reliable and valid assessment of the quality of life of women with ovarian cancer, and is appropriate as a brief quality of life assessment in clinical trials and descriptive studies.

UR - http://www.scopus.com/inward/record.url?scp=0035868845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035868845&partnerID=8YFLogxK

U2 - 10.1200/JCO.2001.19.6.1809

DO - 10.1200/JCO.2001.19.6.1809

M3 - Article

C2 - 11251013

AN - SCOPUS:0035868845

VL - 19

SP - 1809

EP - 1817

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 6

ER -